Search

everythinglearnresearchcommunity

for

Search:↓

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Higher androgen levels might make COVID-19 worse, especially in men.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Searches for acne, hair loss, and eczema increased during COVID-19, while searches for other skin issues decreased.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.